Pfizer's next-gen pneumonia shot beats Prevnar 20; Relay targets $175M

💉 Pfizer’s experimental 25-valent pneumococcal shot beats Prevnar 20: The vaccine candidate, codenamed PF-07872412, produced higher geometric mean titers for serotype 3 than Pfizer’s approved 20-valent vaccine in a head-to-head Phase 2 trial in healthy ...